In prostate cancer, a trial comparing conventional- versus high-dose conformal radiotherapy has shown that increasing the dose can improve outcome, with only slight increases in toxicity.
Related Articles
Senza categoria
NEWSROUND
Editorial
The best decisions come from the best run MDTs
Spotlight on
Leave a Reply